Status:
UNKNOWN
To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Macrosomia, Fetal
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
This study is a randomized, controlled, observational study. 150 nulliparous women with estimated fetal weight ≥3500g at 39-40 weeks of gestation will be enrolled as subjects in the two groups is 1:1....
Eligibility Criteria
Inclusion
- singleton head position pregnancy, negative Down's screening and /or NIPT screening, no malformation was found, with slight/without pregnancy complications -
Exclusion
- twin or multiple pregnancy, scar uterus, with contraindications to vaginal delivery, estimated fetal weight \>4500g
- \-
Key Trial Info
Start Date :
January 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 17 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05197101
Start Date
January 17 2022
End Date
March 17 2023
Last Update
January 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.